Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
Two-day long National Health Summit highlighted progress under the NHM and called for data-driven and SDG-aligned health system reforms
SPARC enters definitive agreement to monetise rare paediatric disease PRV, unlocking capital for R&D and strategic growth
The company doses first patient in US study of Deraphan, as Dolby Ventures joins €53M Series B to support neuropsychiatric innovation
The aim is to simplify and strengthen long-term control of airway disease through triple therapy in one device
Subscribe To Our Newsletter & Stay Updated
